Schonfeld Strategic Advisors’s Health Catalyst HCAT Stock Holding History

Schonfeld Strategic Advisors’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59K	Buy	+29,653	New	+$42.8K	﹤0.01%	2366
2023 Q1	–	Sell	-14,900	Closed	-$158K	–	2309
2022 Q4	$158K	Sell	14,900 -111,800	-88%	-$1.08M	﹤0.01%	2059
2022 Q3	$1.23M	Buy	126,700 +40,900	+48%	+$542K	0.01%	1138
2022 Q2	$1.24M	Buy	85,800 +40,700	+90%	+$694K	0.01%	923
2022 Q1	$1.18M	Buy	45,100 +26,400	+141%	+$749K	0.01%	916
2021 Q4	$740K	Buy	18,700 +200	+1%	+$9.12K	0.01%	1082
2021 Q3	$925K	Buy	18,500 +613	+3%	+$33.4K	0.01%	993
2021 Q2	$993K	Buy	17,887 +1,587	+10%	+$84.5K	0.01%	936
2021 Q1	$762K	Buy	16,300 +3,400	+26%	+$165K	0.01%	990
2020 Q4	$561K	Buy	+12,900	New	+$476K	0.01%	1007

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

CDC Financial Chicago, Illinois $239M AUM

PVM

Palogic Value Management Dallas, Texas $306M AUM 15.41% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Schonfeld Strategic Advisors's HCAT Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in Health Catalyst (HCAT) in Q2 2026: 29,653 shares worth $59K. The stake represents ﹤0.01% of the portfolio and ranks #2366 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in HCAT as recently as Q4 2022.

Schonfeld Strategic Advisors first reported a position in HCAT in Q4 2020 and has held it in 10 quarters since. The position peaked at $1.24M in Q2 2022. 126 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

Schonfeld Strategic Advisors held 29,653 shares of Health Catalyst worth $59K as of Q2 2026.
Health Catalyst was a new Schonfeld Strategic Advisors position in Q2 2026.
Health Catalyst made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #2366 holding.
Schonfeld Strategic Advisors first reported a position in Health Catalyst in Q4 2020 and has held it in 10 quarters since.
Schonfeld Strategic Advisors's Health Catalyst position peaked at $1.24M in Q2 2022.
126 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.